Sam Hariry

656 total citations
7 papers, 464 citations indexed

About

Sam Hariry is a scholar working on Pediatrics, Perinatology and Child Health, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Sam Hariry has authored 7 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pediatrics, Perinatology and Child Health, 2 papers in Pathology and Forensic Medicine and 2 papers in Oncology. Recurrent topics in Sam Hariry's work include Pharmacological Effects and Toxicity Studies (3 papers), Drug Transport and Resistance Mechanisms (2 papers) and Gastroesophageal reflux and treatments (1 paper). Sam Hariry is often cited by papers focused on Pharmacological Effects and Toxicity Studies (3 papers), Drug Transport and Resistance Mechanisms (2 papers) and Gastroesophageal reflux and treatments (1 paper). Sam Hariry collaborates with scholars based in Switzerland, United States and Germany. Sam Hariry's co-authors include Olivier Pétricoul, Robert G. Perry, Didier Laurent, Ronenn Roubenoff, Jens Præstgaard, Daniel Rooks, Estelle Lach‐Trifilieff, Sam Rebello, Venkateswar Jarugula and Robert Schmouder and has published in prestigious journals such as Journal of the American Geriatrics Society, Movement Disorders and Cephalalgia.

In The Last Decade

Sam Hariry

7 papers receiving 457 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sam Hariry Switzerland 7 163 136 120 92 72 7 464
Mai A. Abd El Fattah Egypt 13 167 1.0× 90 0.7× 146 1.2× 144 1.6× 39 0.5× 20 522
Gökhan S. Hotamisligil United States 11 373 2.3× 243 1.8× 85 0.7× 83 0.9× 33 0.5× 11 838
Amalia Merelli Argentina 15 201 1.2× 88 0.6× 78 0.7× 33 0.4× 78 1.1× 19 579
Stéphane Nion France 9 345 2.1× 128 0.9× 67 0.6× 39 0.4× 70 1.0× 12 642
Madeleine Roy Canada 15 184 1.1× 62 0.5× 192 1.6× 327 3.6× 39 0.5× 24 910
Nicole Nametz United States 7 189 1.2× 94 0.7× 38 0.3× 64 0.7× 104 1.4× 7 570
Satoe Shimoda‐Matsubayashi Japan 8 385 2.4× 98 0.7× 116 1.0× 157 1.7× 19 0.3× 9 725
Jennifer Brelsfoard United States 8 139 0.9× 119 0.9× 64 0.5× 103 1.1× 40 0.6× 12 503
Yan Ping Zhang China 10 149 0.9× 278 2.0× 112 0.9× 30 0.3× 74 1.0× 19 484

Countries citing papers authored by Sam Hariry

Since Specialization
Citations

This map shows the geographic impact of Sam Hariry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sam Hariry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sam Hariry more than expected).

Fields of papers citing papers by Sam Hariry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sam Hariry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sam Hariry. The network helps show where Sam Hariry may publish in the future.

Co-authorship network of co-authors of Sam Hariry

This figure shows the co-authorship network connecting the top 25 collaborators of Sam Hariry. A scholar is included among the top collaborators of Sam Hariry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sam Hariry. Sam Hariry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Rooks, Daniel, Jens Præstgaard, Sam Hariry, et al.. (2017). Treatment of Sarcopenia with Bimagrumab: Results from a Phase II, Randomized, Controlled, Proof‐of‐Concept Study. Journal of the American Geriatrics Society. 65(9). 1988–1995. 157 indexed citations
2.
Gomez‐Mancilla, Baltazar, Ronald Brand, Tim Jürgens, et al.. (2013). Randomized, multicenter trial to assess the efficacy, safety and tolerability of a single dose of a novel AMPA receptor antagonist BGG492 for the treatment of acute migraine attacks. Cephalalgia. 34(2). 103–113. 35 indexed citations
3.
Berg, Daniela, Jana Godau, Claudia Trenkwalder, et al.. (2011). AFQ056 treatment of levodopa‐induced dyskinesias: Results of 2 randomized controlled trials. Movement Disorders. 26(7). 1243–1250. 145 indexed citations
4.
Rebello, Sam, Sally Zhao, Sam Hariry, et al.. (2011). Intestinal OATP1A2 inhibition as a potential mechanism for the effect of grapefruit juice on aliskiren pharmacokinetics in healthy subjects. European Journal of Clinical Pharmacology. 68(5). 697–708. 58 indexed citations
5.
Schmouder, Robert, Sam Hariry, & Olivier David. (2011). Placebo-controlled study of the effects of fingolimod on cardiac rate and rhythm and pulmonary function in healthy volunteers. European Journal of Clinical Pharmacology. 68(4). 355–362. 32 indexed citations
6.
Rebello, Sam, et al.. (2011). Effect of Cyclosporine on the Pharmacokinetics of Aliskiren in Healthy Subjects. The Journal of Clinical Pharmacology. 51(11). 1549–1560. 22 indexed citations
7.
Rebello, Sam, et al.. (2010). Effect of Verapamil on the Pharmacokinetics of Aliskiren in Healthy Participants. The Journal of Clinical Pharmacology. 51(2). 218–228. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026